Header Logo

JEAN H TAYAR

TitleAssociate Professor
InstitutionMD Anderson
DepartmentGeneral Internal Medicine
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Kim ST, Chu Y, Misoi M, Suarez-Almazor ME, Tayar JH, Lu H, Buni M, Kramer J, Rodriguez E, Hussain Z, Neelapu SS, Wang J, Shah AY, Tannir NM, Campbell MT, Gibbons DL, Cascone T, Lu C, Blumenschein GR, Altan M, Lim B, Valero V, Loghin ME, Tu J, Westin SN, Naing A, Garcia-Manero G, Abdel-Wahab N, Tawbi HA, Hwu P, Oliva ICG, Davies MA, Patel SP, Zou J, Futreal A, Diab A, Wang L, Nurieva R. Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy. Nat Commun. 2024 Jul 04; 15(1):5621. PMID: 38965214; PMCID: PMC11224259.
      Citations:    Fields:    
    2. Li YJ, Prieto VG, Tayar J. Case of new-onset scleromyxoedema-scleroedema spectrum disorder in a patient with CLL. RMD Open. 2023 11 27; 9(4). PMID: 38016711; PMCID: PMC10685934.
      Citations:    Translation:Humans
    3. Lopez-Olivo MA, Kachira JJ, Buni M, Kim ST, Lu H, Tayar JH, Duhon GF, Ruiz JI, Bingham CO, Calabrese C, Volk RJ, Suarez-Almazor ME. Learning Needs of Patients with Cancer and a Pre-Existing Autoimmune Disease Who Are Candidates to Receive Immune Checkpoint Inhibitors. Cancers (Basel). 2023 Aug 07; 15(15). PMID: 37568819; PMCID: PMC10416973.
      Citations: 1     
    4. Fa'ak F, Buni M, Falohun A, Lu H, Song J, Johnson DH, Zobniw CM, Trinh VA, Awiwi MO, Tahon NH, Elsayes KM, Ludford K, Montazari EJ, Chernis J, Dimitrova M, Sandigursky S, Sparks JA, Abu-Shawer O, Rahma O, Thanarajasingam U, Zeman AM, Talukder R, Singh N, Chung SH, Grivas P, Daher M, Abudayyeh A, Osman I, Weber J, Tayar JH, Suarez-Almazor ME, Abdel-Wahab N, Diab A. Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events. J Immunother Cancer. 2023 06; 11(6). PMID: 37328287; PMCID: PMC10277540.
      Citations: 7     Fields:    Translation:Humans
    5. Kim ST, Chu Y, Misoi M, Suarez-Almazor ME, Tayar JH, Lu H, Buni M, Kramer J, Rodriguez E, Hussain Z, Neelapu SS, Wang J, Shah AY, Tannir NM, Campbell MT, Gibbons DL, Cascone T, Lu C, Blumenschein GR, Altan M, Lim B, Valero V, Loghin ME, Tu J, Westin SN, Naing A, Garcia-Manero G, Abdel-Wahab N, Tawbi HA, Hwu P, Oliva ICG, Davies MA, Patel SP, Zou J, Futreal A, Diab A, Wang L, Nurieva R. Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy. Nat Commun. 2022 04 12; 13(1):1970. PMID: 35413951; PMCID: PMC9005525.
      Citations: 1     Fields:    Translation:HumansCells
    6. Robinson JD, Karam-Hage M, Kypriotakis G, Beneventi D, Blalock JA, Cui Y, Gonzalez R, Tayar J, Chaftari P, Cinciripini PM. Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center. Am J Addict. 2022 05; 31(3):236-241. PMID: 35347796; PMCID: PMC9117427.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    7. DiPeri TP, Demirhan M, Karp DD, Fu S, Hong DS, Subbiah V, Lim J, Ballester LY, Tayar JH, Suarez-Almazor ME, Javle M, Meric-Bernstam F. Corticosteroid-Refractory Myositis After Dual BRAF and MEK Inhibition in a Patient with BRAF V600E-Mutant Metastatic Intrahepatic Cholangiocarcinoma. J Immunother Precis Oncol. 2022 Feb; 5(1):26-30. PMID: 35663835; PMCID: PMC9138421.
      Citations:    
    8. Kim ST, Tayar J, Fu S, Ke D, Norry E, Sun A, Miller J, Hong DS. Newly developed pseudogout arthritis after therapy with MAGE-A4 directed TCR T cells responded to treatment with tocilizumab. J Immunother Cancer. 2021 07; 9(7). PMID: 34233963; PMCID: PMC8264871.
      Citations:    Fields:    Translation:Humans
    9. Ragoonanan D, Khazal SJ, Mejia R, Ewing L, Durand JB, Bashoura L, Tayar J, Dailey Garnes N, Petropoulos D, Tewari P, Bhatti M, Ahmad AH, Cortes J, Razvi S, McBeth K, Swinford R, Shoberu B, Waseemuddin W, Chi L, Gill JB, Zaky W, Daw N, Gutierrez C, Tereffe W, Kebriaei P, Rezvani K, Shpall EJ, Champlin RE, Mahadeo KM. Case Discussion and Literature Review: Cancer Immunotherapy, Severe Immune-Related Adverse Events, Multi-Inflammatory Syndrome, and Severe Acute Respiratory Syndrome Coronavirus 2. Front Oncol. 2021; 11:625707. PMID: 33614514; PMCID: PMC7891040.
      Citations: 3     
    10. Abdel-Wahab N, Diab A, Yu RK, Futreal A, Criswell LA, Tayar JH, Dadu R, Shannon V, Shete SS, Suarez-Almazor ME. Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors. Cancer Immunol Immunother. 2021 Jul; 70(7):1939-1949. PMID: 33409738; PMCID: PMC10992432.
      Citations: 5     Fields:    Translation:Humans
    11. Pundole X, Siddhanamatha H, Lin H, Tayar J, Leung CH, Li L, Suarez-Almazor ME, Zamora NV. Overall survival in patients with rheumatoid arthritis and solid malignancies receiving biologic disease-modifying antirheumatic therapy. Clin Rheumatol. 2020 Oct; 39(10):2943-2950. PMID: 32803571; PMCID: PMC10556973.
      Citations:    Fields:    Translation:Humans
    12. Abdel-Wahab N, Tayar JH, Fa'ak F, Sharma G, Lopez-Olivo MA, Yousif A, Shagroni T, Al-Hawamdeh S, Rojas-Hernandez CM, Suarez-Almazor ME. Systematic review of observational studies reporting antiphospholipid antibodies in patients with solid tumors. Blood Adv. 2020 04 28; 4(8):1746-1755. PMID: 32337583; PMCID: PMC7189282.
      Citations: 3     Fields:    Translation:Humans
    13. Pundole X, Siddhanamatha H, Lin H, Tayar J, Hong LC, Li L, Suarez-Almazor ME, Zamora NV. Utilization of biologic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer. Clin Rheumatol. 2020 Mar; 39(3):787-794. PMID: 31853733.
      Citations: 1     Fields:    Translation:Humans
    14. Mamlouk O, Selamet U, Machado S, Abdelrahim M, Glass WF, Tchakarov A, Gaber L, Lahoti A, Workeneh B, Chen S, Lin J, Abdel-Wahab N, Tayar J, Lu H, Suarez-Almazor M, Tannir N, Yee C, Diab A, Abudayyeh A. Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience. J Immunother Cancer. 2019 01 06; 7(1):2. PMID: 30612580; PMCID: PMC6322290.
      Citations: 82     Fields:    Translation:Humans
    15. Donisan T, Balanescu DV, Mouhayar E, Tayar J, Iliescu C. Coronary Lesions in Takayasu Arteritis With Chronic Myelogenous Leukemia - Intravascular Assessment With Optical Coherence Tomography and Fractional Flow Reserve. Circ J. 2018 12 25; 83(1):245-246. PMID: 29952342.
      Citations: 2     Fields:    Translation:Humans
    16. Shah M, Tayar JH, Abdel-Wahab N, Suarez-Almazor ME. Myositis as an adverse event of immune checkpoint blockade for cancer therapy. Semin Arthritis Rheum. 2019 Feb; 48(4):736-740. PMID: 29909921.
      Citations: 36     Fields:    Translation:Humans
    17. Kim ST, Tayar J, Trinh VA, Suarez-Almazor M, Garcia S, Hwu P, Johnson DH, Uemura M, Diab A. Successful treatment of arthritis induced by checkpoint inhibitors with tocilizumab: a case series. Ann Rheum Dis. 2017 Dec; 76(12):2061-2064. PMID: 28830882.
      Citations: 58     Fields:    Translation:Humans
    18. El Chaer F, Mori N, Shah D, Oliver N, Wang E, Jan A, Doan V, Tverdek F, Tayar J, Ariza-Heredia E, Chemaly RF. Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients: A case series. Antiviral Res. 2016 11; 135:91-96. PMID: 27594527.
      Citations: 3     Fields:    Translation:HumansCells
    19. Tang VK, Huh YO, Tayar JH, Rojas Hernandez CM. Primary autoimmune myelofibrosis as etiology of pancytopenia mimicking myelodysplastic syndrome. Leuk Lymphoma. 2016; 57(3):731-4. PMID: 26422082.
      Citations: 1     Fields:    Translation:Humans
    20. Mouhayar E, Tayar J, Fasulo M, Aoun R, Massey M, Abi-Aad S, Iliescu C, Ahrar K, Huynh T. Outcome of acute limb ischemia in cancer patients. Vasc Med. 2014 Apr; 19(2):112-117. PMID: 24532704.
      Citations: 2     Fields:    
    21. Tayar JH, Lopez-Olivo MA, Suarez-Almazor ME. Febuxostat for treating chronic gout. Cochrane Database Syst Rev. 2012 Nov 14; 11:CD008653. PMID: 23152264; PMCID: PMC4058893.
      Citations: 13     Fields:    Translation:Humans
    22. Lopez-Olivo MA, Tayar JH, Martinez-Lopez JA, Pollono EN, Cueto JP, Gonzales-Crespo MR, Fulton S, Suarez-Almazor ME. Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis. JAMA. 2012 Sep 05; 308(9):898-908. PMID: 22948700.
      Citations: 82     Fields:    Translation:Humans
    23. Lopez-Olivo MA, Tayar JH, Suarez-Almazor ME. The updated guidelines on the use of rituximab in rheumatoid arthritis. Rheumatology (Oxford). 2011 Dec; 50(12):2153-4. PMID: 21546350.
      Citations: 1     Fields:    Translation:Humans
    24. Tayar JH, Suarez-Almazor ME. New understanding and approaches to treatment in rheumatoid arthritis. Br Med Bull. 2010; 94:201-14. PMID: 20200013.
      Citations: 8     Fields:    Translation:Humans
    25. Mullins ME, Barnes BJ. Hyperosmolar metabolic acidosis and intravenous Lorazepam. N Engl J Med. 2002 Sep 12; 347(11):857-8; author reply 857-8. PMID: 12226165.
      Citations: 2     Fields:    Translation:Humans
    26. Tayar J, Jabbour G, Saggi SJ. Severe hyperosmolar metabolic acidosis due to a large dose of intravenous lorazepam. N Engl J Med. 2002 Apr 18; 346(16):1253-4. PMID: 11961161.
      Citations: 4     Fields:    Translation:HumansCells
    27. Outcome of acute limb ischemia in cancer patients. Vascular Medicine (United Kingdom). 19:112-117.
    28. Case 181. Radiology. 262:361-363.
    29. Adalimumab. International Journal of Clinical Rheumatology. 8:165-184.
    30. Primary autoimmune myelofibrosis as etiology of pancytopenia mimicking myelodysplastic syndrome. Leukemia and Lymphoma.
    31. Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients. Antiviral Research. 135:91-96.
    TAYAR's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (119)
    Explore
    _
    Co-Authors (62)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _